M. Molnár

Lack of age-related clinical progression in PGC-1α-deficient mice – implications for mitochondrial encephalopathies

P. Klivényi, L. Vécsei, L. Szalardy, 2016, Behavioural Brain Research.

Non-motor Behavioral Alterations of PGC-1α-Deficient Mice – A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression

P. Klivényi, G. Veres, L. Vécsei, 2018, Front. Behav. Neurosci..

Effect of MPTP on mRNA expression of PGC-1α in mouse brain

P. Klivényi, L. Vécsei, D. Zádori, 2017, Brain Research.

Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner

P. Klivényi, L. Vécsei, G. Nagy, 2015, Neuropharmacology.

Low dosage of rimonabant leads to anxiolytic like behavior in a cannabinoid receptor independent manner via inhibiting expression levels and G-protein activity of kappa opioid receptors

P. Klivényi, L. Vécsei, G. Nagy, 2015 .

High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice.

P. Klivényi, L. Vécsei, L. Szalardy, 2016, Acta neurobiologiae experimentalis.

Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease

P. Klivényi, G. Veres, L. Vécsei, 2015, Pharmacology Biochemistry and Behavior.